Based on the Predictive Oncology Inc stock forecast from 0 analysts, the average analyst target price for Predictive Oncology Inc is not available over the next 12 months. Predictive Oncology Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Predictive Oncology Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Predictive Oncology Inc’s stock price was USD 0.87. Predictive Oncology Inc’s stock price has changed by -9.58% over the past week, -21.80% over the past month and -25.81% over the last year.
No recent analyst target price found for Predictive Oncology Inc
No recent average analyst rating found for Predictive Oncology Inc
Company Overview Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania. Read Less
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides serv...Read More
Frequently Asked Questions About Predictive Oncology Inc (POAI) Stock
Stock Target Advisor's fundamental analysis for Predictive Oncology Inc's stock is Bearish.
Unfortunately we do not have enough data on POAI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on POAI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on POAI's stock to indicate if its overvalued.
The last closing price of POAI's stock was USD 0.87.
The most recent market capitalization for POAI is USD 8.93M.
Unfortunately we do not have enough analyst data on POAI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Predictive Oncology Inc's stock.
As per our most recent records Predictive Oncology Inc has 0 Employees.
Predictive Oncology Inc's registered address is 91 43rd Street, Pittsburgh, PA, United States, 15201.
You can get more information about it from Predictive Oncology Inc's website at https://www.predictive-oncology.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Predictive Oncology Inc (POAI) Stock
Stock Target Advisor's fundamental analysis for Predictive Oncology Inc's stock is Bearish.
Unfortunately we do not have enough data on POAI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on POAI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on POAI's stock to indicate if its overvalued.
The last closing price of POAI's stock was USD 0.87.
The most recent market capitalization for POAI is USD 8.93M.
Unfortunately we do not have enough analyst data on POAI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Predictive Oncology Inc's stock.
As per our most recent records Predictive Oncology Inc has 0 Employees.
Predictive Oncology Inc's registered address is 91 43rd Street, Pittsburgh, PA, United States, 15201.
You can get more information about it from Predictive Oncology Inc's website at https://www.predictive-oncology.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for POAI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
